165 related articles for article (PubMed ID: 32712094)
1. Inhibition of CFTR-mediated intestinal chloride secretion by a fungus-derived arthropsolide A: Mechanism of action and anti-diarrheal efficacy.
Akrimajirachoote N; Satitsri S; Sommart U; Rukachaisirikul V; Muanprasat C
Eur J Pharmacol; 2020 Oct; 885():173393. PubMed ID: 32712094
[TBL] [Abstract][Full Text] [Related]
2. A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas.
Muangnil P; Satitsri S; Tadpetch K; Saparpakorn P; Chatsudthipong V; Hannongbua S; Rukachaisirikul V; Muanprasat C
Biochem Pharmacol; 2018 Apr; 150():293-304. PubMed ID: 29475061
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of intestinal chloride secretion by piperine as a cellular basis for the anti-secretory effect of black peppers.
Pongkorpsakol P; Wongkrasant P; Kumpun S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2015 Oct; 100():271-80. PubMed ID: 26297981
[TBL] [Abstract][Full Text] [Related]
4. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease.
Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 22186622
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cAMP-activated intestinal chloride secretion by diclofenac: cellular mechanism and potential application in cholera.
Pongkorpsakol P; Pathomthongtaweechai N; Srimanote P; Soodvilai S; Chatsudthipong V; Muanprasat C
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3119. PubMed ID: 25188334
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel chalcone derivative inhibiting CFTR chloride channel via AMPK activation and its anti-diarrheal application.
Yibcharoenporn C; Chusuth P; Jakakul C; Rungrotmongkol T; Chavasiri W; Muanprasat C
J Pharmacol Sci; 2019 Jul; 140(3):273-283. PubMed ID: 31444000
[TBL] [Abstract][Full Text] [Related]
7. Antidiarrheal efficacy of a quinazolin CFTR inhibitor on human intestinal epithelial cell and in mouse model of cholera.
Patanayindee J; Muanprasat C; Soodvilai S; Chatsudthipong V
Indian J Pharmacol; 2012; 44(5):619-23. PubMed ID: 23112425
[TBL] [Abstract][Full Text] [Related]
8. Natural statin derivatives as potential therapy to reduce intestinal fluid loss in cholera.
Noitem R; Pongkorpsakol P; Changsen C; Sukpondma Y; Tansakul C; Rukachaisirikul V; Muanprasat C
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010989. PubMed ID: 36490300
[TBL] [Abstract][Full Text] [Related]
9. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor.
Thiagarajah JR; Broadbent T; Hsieh E; Verkman AS
Gastroenterology; 2004 Feb; 126(2):511-9. PubMed ID: 14762788
[TBL] [Abstract][Full Text] [Related]
10. Activation of constitutive androstane receptor inhibits intestinal CFTR-mediated chloride transport.
Kittayaruksakul S; Sawasvirojwong S; Noitem R; Pongkorpsakol P; Muanprasat C; Chatsudthipong V
Biomed Pharmacother; 2019 Mar; 111():1249-1259. PubMed ID: 30841439
[TBL] [Abstract][Full Text] [Related]
11. CFTR pharmacology and its role in intestinal fluid secretion.
Thiagarajah JR; Verkman AS
Curr Opin Pharmacol; 2003 Dec; 3(6):594-9. PubMed ID: 14644010
[TBL] [Abstract][Full Text] [Related]
12. Calcium-sensing receptor activator cinacalcet for treatment of cyclic nucleotide-mediated secretory diarrheas.
Chu T; Yottasan P; Goncalves LS; Oak AA; Lin R; Tse M; Donowitz M; Cil O
Transl Res; 2024 Jan; 263():45-52. PubMed ID: 37678755
[TBL] [Abstract][Full Text] [Related]
13. CFTR inhibitors for treating diarrheal disease.
Thiagarajah JR; Verkman AS
Clin Pharmacol Ther; 2012 Sep; 92(3):287-90. PubMed ID: 22850599
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms underlying the inhibitory effect of flufenamic acid on chloride secretion in human intestinal epithelial cells.
Pongkorpsakol P; Yimnual C; Chatsudthipong V; Rukachaisirikul V; Muanprasat C
J Pharmacol Sci; 2017 Jun; 134(2):93-100. PubMed ID: 28651800
[TBL] [Abstract][Full Text] [Related]
15. Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins.
Cil O; Phuan PW; Gillespie AM; Lee S; Tradtrantip L; Yin J; Tse M; Zachos NC; Lin R; Donowitz M; Verkman AS
FASEB J; 2017 Feb; 31(2):751-760. PubMed ID: 27871064
[TBL] [Abstract][Full Text] [Related]
16. Activation of AMP-activated protein kinase by a plant-derived dihydroisosteviol in human intestinal epithelial cell.
Muanprasat C; Sirianant L; Sawasvirojwong S; Homvisasevongsa S; Suksamrarn A; Chatsudthipong V
Biol Pharm Bull; 2013; 36(4):522-8. PubMed ID: 23343619
[TBL] [Abstract][Full Text] [Related]
17. Identification of new small molecule inhibitors of cystic fibrosis transmembrane conductance regulator protein: in vitro and in vivo studies.
Muanprasat C; Kaewmokul S; Chatsudthipong V
Biol Pharm Bull; 2007 Mar; 30(3):502-7. PubMed ID: 17329846
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.
Ma T; Thiagarajah JR; Yang H; Sonawane ND; Folli C; Galietta LJ; Verkman AS
J Clin Invest; 2002 Dec; 110(11):1651-8. PubMed ID: 12464670
[TBL] [Abstract][Full Text] [Related]
19. CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.
Verkman AS; Lukacs GL; Galietta LJ
Curr Pharm Des; 2006; 12(18):2235-47. PubMed ID: 16787252
[TBL] [Abstract][Full Text] [Related]
20. Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas.
Oak AA; Chhetri PD; Rivera AA; Verkman AS; Cil O
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33400691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
